Austar Lifesciences Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 855.376 million compared to CNY 517.985 million a year ago. Operating income was CNY 246.361 million compared to CNY 12.066 million a year ago. Net income was CNY 217.870 million compared to CNY 12.782 million a year ago. Basic earnings per share from continuing operations was CNY 0.43 compared to CNY 0.02 a year ago.